Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday posted a better-than-feared fourth-quarter profit, which came as a relief to ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

The equity portfolio returned 1.28% in the quarter, compared to 2.41% for the S&P 500 Index ... and Income Fund highlighted stocks like Elevance Health, Inc. (NYSE:ELV) in the fourth quarter ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target is $463.00. Whit Mayo has given his Buy rating due ...

The S&P 500, the large cap index, is widely followed as a measure of the health of the U. S. economy. The Nasdaq-100 is widely followed as a measure mainly of the big tech and social media stocks ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The equity portfolio returned 1.28% in the quarter, compared to 2.41% for the S&P 500 Index. The fixed-income portfolio ... Oakmark Equity and Income Fund highlighted stocks like Elevance Health, Inc.